Niagen Bioscience Inc
NASDAQ:NAGEBiotechnology
Healthcare
$1.94 +3.31%
+$0.11 today
- Market cap
- $153.64M
- Beta
- 2.06
- P/E (TTM)
- 14.9
- EPS (TTM)
- $0.23
52W Low $3.35High $14.69
Volume 0.52M
Average 0.86M
Price history
Niagen Bioscience Inc SEC filings
Start with how the market priced the stock, then connect its moves to the disclosures filed with the SEC.
Price history
Dividend-adjusted closing price
Period change
-71.88%
Period high
$7.04
Period low
$1.94
Latest
$1.94
SEC filings
What has the company disclosed?
Browse annual, quarterly, and current reports and other filings by form type.
SEC Filings
Recent regulatory filings
| Form | Filing Date | Accepted | |
|---|---|---|---|
| 10-Q | Nov 4, 2026 | Nov 4, 2026 | |
| 8-K | Nov 4, 2026 | Nov 4, 2026 |
Competitors
Who does Niagen Bioscience Inc compete with?
Open similar companies to compare their filings and price history.
Competitors
Peer companies in the same sector
Questions
Filing questions
Common questions about NAGE's filings, answered from its disclosures.
What is the latest NAGE filing?
The latest filing shown is 10-Q dated Nov 4, 2026.
How many recent filings does NAGE have?
Intrinsic Alpha currently shows 2 recent filings for NAGE.
Continue the stock analysis
Jump to another research area for this company.